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Abstract
Background: Discussion concerning Carbohydrate
Restriction (CR) and Low Carbohydrate Diet (LCD) has
been continued. Authors formerly proposed insulinogenic
index-carbohydrate 70 g (IGI-carbo70). Along this, C-
peptide index for Carbohydrate-70 g (CPI-Carbo70) is
studied.
Subjects and Methods: Subjects were 46 patients (62.5
yo. in average) with Type 2 diabetes mellitus (T2DM) and
admitted for evaluation. CR diet was given on day 1-2 with
60% carbohydrates, 25% lipids and 15% protein with 1400
kcal/day. On day 2, breakfast with Carbo70 was given, and
glucose and C-peptide (CP) were measured at 0 and 30
minutes and analyzed.
Results: As basal data, average HbA1c was 8.1%, median
HbA1c, average daily glucose, median M value was 7.7%,
187 mg/dL, 71, respectively. In response to Carbo70,
median values of glucose-0, glucose-30, delta-glucose,
CP-0, CP-30, delta-CP was 142, 186, 22 mg/dL, 0.9, 1.4, 0.4
ng/mL, respectively. CPI-Carbo70 was 1.54 in median.
There were significant correlation between glucose and
CP on 0, 30min, delta-0-30min (p<0.01). Significant
correlation was observed between CPI and HbA1c, CPI
and M value (p<0.01).
Discussion and Conclusion: CPI-Carbo70 might be useful
for evaluating pancreas function and glucose variability in
clinical research. Current data would become the
fundamental data for the future diabetic practice and
research development.
Keywords: C-peptide (CP); C-peptide index for
Carbohydrate-70 (CPI-Carbo70); Insulinogenic index (IGI);
low carbohydrate diet (LCD); type 2 diabetes mellitus
(T2DM); Calorie Restriction (CR)
Abbreviations: CR: Carbohydrate Restriction; LCD: Low
Carbohydrate Diet; CPI-Carbo70: C-peptide index for
Carbohydrate-70 g; T2DM: Type 2 diabetes mellitus; ADA:
American Diabetes Association; ACP: American College of
Physicians; IDF: International Diabetes Federation; 75 g
OGTT: 75 g oral glucose tolerance test; IGI-Carbo70:
insulinogenic index (IGI)-Carbohydarate70 g; M: Morbus
value; MAGE: mean amplitude of glycemic excursions.
Introduction
Metabolic syndrome (Met-S) has been prevalent in the
world nowadays. It was proposed and investigated from
syndrome X in 1980s associated with insulin resistance [1].
Met-S has been gradually increased with medical, social and
economic problems [2], and it is also defined as a cluster of
mutual metabolic abnormalities accompanied by glucose
metabolism, including dyslipidemia, elevated blood pressure
and central obesity [3].
As mentioned above, impaired glucose metabolism would
exist in the fundamental pathophysiology of Met-S. Patients
with diabetes mellitus have been increasing worldwide [4].
There was recently the changes in the guideline concerning
diabetes. American Diabetes Association (ADA) gave
comments in 2017 [5], which was followed by the joint
algorithm of European Diabetes Society (EASD) 2012 [6]. After
that, American College of Physicians (ACP) proposed the
change in standard value about HbA1c [7], in which the
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management goal for HbA1c in most type 2 diabetic patients
would be 7% or more and less than 8%. Against the concept of
ACP, ADA made an objection comment immediately [8]. Thus,
diabetic management has been in discussion among several
guidelines from medical societies, leading to better clinical
practice with accumulated evidences.
Moreover, there was a large-scale epidemiological study,
which is “The Prospective Urban Rural Epidemiology (PURE)
study”. It included wide data from 140 thousands subjects
from 17-18 countries in the world [9]. The result revealed that
there were higher carbohydrate intake associated with an
increased risk of HR 1.28 of total mortality. Then, it seems to
be recommended to take lower carbohydrate for everyone to
lead a better life [10].
International Diabetes Federation (IDF) summarized and
proposed the Standards of Medical Care in Diabetes [11].
Among this guideline, the crucial points seemed to be
monitoring carbohydrate intake, carbohydrate counting and
experience-based estimation. In the future, continuing
evaluation and investigation of eating patterns and
macronutrient distribution would be beneficial for achieving
better glycemic control.
Regarding the nutritional treatment for diabetes mellitus,
there has been continuing discussion the comparison about
Calorie Restriction (CR) diet and Low Carbohydrate Diet (LCD)
[12,13]. Originally, LCD was initiated by Bernstein who was
physician with type 1 diabetes mellitus (T1DM). After that, LCD
became rather popular and known widely [14]. In Japan,
authors and colleagues have started LCD and developed
medically and socially with Japan LCD promotion association,
and have given adequate therapy for many diabetic patients
with successful treatment [15]. Furthermore, we have
continued LCD research related to lipid metabolism, renal
function, elevated ketone bodies and three types of LCD
formula which are petit, standard and super LCD [16-18].
As we have continued clinical research about CR /LCD, and
related investigation, we have proposed a trial of clinically new
index which is simple and useful method. It is similar
procedure and calculation of insulinogenic index (IGI) to 75 g
oral glucose tolerance test (75 g OGTT). Subjects have
breakfast including 70 g of carbohydrate, and blood samples
are drawn before and 30 minutes after for the measurement
of blood glucose and immunoreactive insulin (IRI) [19]. It is
called insulinogenic index (IGI)-Carbohydarate 70 g (IGI-
Carbo70), and seems to become useful for clinical diabetic
practice.
We develop this evaluation method, try to use the
measurement of C-Peptide (CP) value instead of IRI and report
the data in this study.
Subjects and Methods
In current study, the subjects were 46 patients (M/F 19/27)
enrolled with Type 2 diabetes mellitus (T2DM). Fundamental
data were shown in Table 1. Average age is 62.5 +/- 10.9 years
old (mean +/- standard deviation) and 65 (55- 68) years old
(median [25-75%]). They were admitted to the hospital for 14
days, which purpose would be further evaluation, examination
and treatment. They were in-patient and on our protocol of CR
and LCD nutritional therapy.
Methods are described in the following: 1) Formula diet for
CR was given to the subjects on day 1 and 2. CR includes 60%
carbohydrates, 25% lipids and 15% protein with 1400 kcal/day.
2) Formula meal of super LCD was provided from 3 to 14 days,
including 12% carbohydrates, 64% lipids and 24% protein with
1400 kcal/day.
This protocol with CR and LCD has been continued in our
clinical research for years. However, this study has only
indicated for the breakfast on day 2. Formula CR meal has 840
kcal of carbohydrate per day including 210g of carbohydrate
totally in 3 meals. According to the guideline of Japan Diabetes
Society (JDS), standard nutrients balance of PFC (protein, fat,
carbohydrate) are 60% carbohydrates, 25% lipids and 15%
protein [20]. In this manner, formula breakfast including 70g of
carbohydrate was provided after overnight fasting.
Detail protocol is shown as follows: 1) Basal biomarkers
were checked in fasting situation on day 2, 2) blood glucose
level and C-peptide value were measured before breakfast (0
min), 3) patient eats breakfast with 70 g of carbohydrate, 4)
levels of glucose and C-peptide were measured 30 minutes
after breakfast, 5) both markers on 0, 30 min and increment of
glucose and C-peptide were measured, 6) the index of ratio for
increment of C-peptide / glucose was calculated as CPI-
Carbo70, 7) The detail calculation method is as follows:
Increment is described by delta, delta-glucose and delta-CP are
calculated, delta-CP/delta-glucose x 100 equals CPI-Carbo70.
Morbus value and glucose profile
As to the daily glucose profile on day 2, blood glucose was
measured 7 times a day, which time was 8, 10, 12, 14, 17, 19,
22 h. From these data, average glucose level and Morbus (M)
value were calculated.
M value has been known the useful index which indicates
both blood sugar level and mean amplitude of glycemic
excursions (MAGE) [21,22]. From the glucose profiles, average
glucose level and M value could be calculated. M value is
useful for supposing the status of MAGE. M value is
characteristic for a logarithmic transformation of the deviation
of glycemia from an arbitrary assigned “ideal” glucose value. It
includes the degree of mean glucose value and glucose swings
[21-23].
The definition of M value has been as follows: M=MBS +
MW, where MW=(maximum blood glucose − minimum
glucose)/20; MBS=the mean of MBSBS; MBSBS=individual M-
value for each blood glucose value calculated as (absolute
value of [10 × log (blood glucose value/120)])3 [21-23].
The significance and interpretation of M value has been in
the following: the standard range is <180, borderline is
180-320 and abnormal range is >320. According to some
experimental research, similar results were taken for
measuring 7 times or 20 times a day [22- 24]. Furthermore, its
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revealed similar result compared with continuous glucose
monitoring (CGM) [22,24,25].
Statistical analyses
In this study, data were indicated as the mean +/- standard
deviation (SD) and also as median, quartile of 25% and 75%
according to the biomarkers. In statistical analyses, correlation
coefficients were calculated by using Spearman test of the
Microsoft Excel analytical tool, which is Four steps Excel
Statistics 4th edition [26].
Ethical considerations
This investigation was conducted in compliance with the
ethical principles of the Declaration of Helsinki. It was also
conducted with Japan’s Act on the Protection of Personal
Information along with the Ministerial Ordinance on Good
Clinical Practice (GCP) for Drug (Ordinance of Ministry of
Health and Welfare No. 28 of March 27, 1997).
In addition, an ethical committee was established including
doctor, nurse, pharmacist and expert in the medical and legal
specialty. We have discussed enough and got the conclusion
that this this study has been valid and agreed without any
problems. Furthermore, informed consents and written paper
agreements have been obtained from the all subjects. The
study has been registered with UMIN #R000031211.
Results
Basal data
Current study enrolled 46 patients with T2DM. Fundamental
diabetic data were shown in Table 1. Average glucose level was
205 mg/dL and median M value was 71.
Table 1 Subjects and basal data.
Mean ± SD Median [25-75%]
Subjects
number (M/F)
46 (19/27) 46 (19/27)
age (years old) 62.5 ± 10.9 65 [55-68]
Glucose profile
HbAlc (%) 8.1 ±1.8 7.7 [7.0-9.2]
average glucose (mg/d1.) 204 ± 71.2 187 [161-228]
Morbus value 187 ± 256 71 [43-203]
C-peptide index for Carbo70
Responses of blood glucose and C-peptide (CP) for
carbohydrate 70 g were shown in Table 2. The values are
expressed by average +/- standard deviation and median
[25%-75%]. As median value, delta-glucose, delta-CP, CPI-
Carbo70 was 22 mg/dL, 0.4 ng/mL, 1.54, respectively.
Table 2 Responses of Glucose and C-peptide for Carbo-70.
 
Mean ±
SD
Median
[25-75%]
Response of blood glucose before ( 0
min)
163 ±
54.9 142 [134-186]
after (30 min)
195 ±
65.2 186 [155-214]
increment (∠)
322 ±
26.4 22 [13-46]
Response of C-peptide before ( 0 min)
1.08 ±
0.65 0.9 [0.7-1.4]
after (30 min)
1.52 ±
0.83 1.4 [1.0-1.9]
increment (∠)
0.44 ±
0.41 0.4 [0.8-2.5]
Index of CRP for carbo-70   
ACPR/ABG
1.94 ±
1.51 1.54 [0.8-2.5]
Correlation among biomarkers
There was significant correlation between fasting glucose
and C-peptide (p<0.01) (Figure 1). In response to the loading
of carbohydrate 70g, blood glucose and C-peptide were
measured at 30 min. There was significant correlation
between glucose and-C-peptide on 30 min (p<0.01) (Figure 2).
Figure 1 Correlation between Fasting glucose and C-
peptide.
Figure 2 Correlation between glucose and C-peptide on 30
min.
C-peptide Index (CPI) is calculated by delta-CP/delta-glucose
x 100. There was significant correlation between delta-CP and
delta-glucose (p<0.01) (Figure 3).
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Figure 3 Correlation between delta-glucose and delta-C-
peptide on 0-30 min.
Regarding CPI, two correlations were investigated.
Significant negative correlation was observed between CPI and
HbA1c (p<0.01) (Figure 4). Furthermore, significant negative
correlation was observed between CPI and M value (p<0.01)
(Figure 5).
Figure 4 Correlation between HbA1c and CPI-Carbo70.
Figure 5 Correlation between M value and CPI-Carbo70.
Discussion
Authors and colleagues have continued clinical practice and
research concerning LCD for years [17,18,27]. Furthermore, we
have developed social movement for healthier life through
Japan Low Carbohydrate Diet Promotion Association.
In this study, 70 g of Carbohydrate as a breakfast was used.
Figures 1-3 revealed 3 significant correlations between glucose
and C-peptide in 0 min, 30 min, and delta-0-30min. These high
correlation seems to suggest the validity and usefulness of this
protocol. These statistical precise data in this order (0 min, 30
min, delta-0-30min) was r=0.395 / p=0.0078, r=0.431 /
p=0.0038, r=0.510 / p=0.0005, respectively. Among these,
delta-0-30min showed higher correlation degree, supposing
that delta-glucose and delta-CP may be useful and meaningful
in clinical practice and research.
Furthermore, Figures 4 and 5 revealed significant
correlations between CPI-Carbo70 and HbA1c, CPI-Carbo70
and M value, in which the latter revealed higher degree of
correlation. When compared the difference of numerical
values in HbA1c and M value, the latter has larger difference
result than that of the former. Consequently, it may be more
useful by M value for analyzing biomarkers in related research.
In relation to current study, there have been several reports
concerning the responses of glucose, insulin and C-peptide
against carbohydrate loading on breakfast.
There was a study of postprandial hyperglycemia (PPHG)
after lunch and dinner in the case of with and without
breakfast [28]. The result was that skipping breakfast increases
PPHG with impaired insulin response and lower incremental
GLP-1. It may suggest the influence of breakfast on glucose
regulation that persists throughout the day. Without breakfast,
AUC of blood glucose (0-30 min) of lunch increased by 23.7%,
while AUC of C-peptide decreased by 42.5% after lunch.
However, basal value of C-peptide was 3.7 ng/mL and 1.8
ng/mL, with breakfast and without breakfast, respectively.
Consequently, it seems to be rather difficult to compare the
both and to speculate the detail.
In other study, T2DM patients were investigated with 2
kinds of breakfast provided [29]. One is carbo-breakfast with
PFC=15:20:65%, another is protein-breakfast with
PFC=35:20:45%. When lunch including 65% of carbohydrate
was given to both groups, protein-group showed higher insulin
and C-peptide response, with lower postprandial
hyperglycemia. Insulin, C-peptide and GIP levels showed the
second-meal phenomenon, keeping the glucose
concentrations controlled.
There was also an experiment for glucose increase in four
conditions on ingestion of carbohydrate 50 g [30]. These
protocols are as follows: only rice, salad + rice, rice + yogurt,
and yogurt + rice, respectively. The result for the increment of
blood glucose on 30 minute was 39.0 mg/dL, 19.4 mg/dL, 29.2
mg/dL, 15.9 mg/dL, respectively. The latter three group
revealed reduced postprandial hyperglycemia compared with
only rice group. These results would suggest the effect of
taking salad and/or yogurt together for decreasing the risk of
high glucose.
Furthermore, some reports were found with mixed meal
challenge on breakfast. T2DM patients were provided 3 kinds
of breakfast, which are 1) WB: whey diet 28 g with 42 g total
protein, 2) PB diet: various protein 42 g, 3) CB: high-carbo with
17 g protein [31]. Overall postprandial AUC glucose was
reduced by 12% in PB diet and by 19% in WB diet, compared
with CB diet. Increment of C-peptide would be 7.4, 4.0, 1.0
pg/mL, respectively. After 12 weeks, decrease of HbA1c and
body weight were, 0.89%, 0.6%, 0.36%, and 7.6kg, 6.1 kg, 3.5
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kg, respectively. Thus, whey protein-based breakfast could
become an important adjuvant for T2DM.
Responses of glucose, insulin, C-peptide and Triglyceride
were investigated between Red Meat/Refined Grain Diet and
Dairy/Chicken/Nuts/Whole Grain Diet [32]. In each group,
carbohydrate amount per day and CP-incremental AUC were
218 g vs 181 g, 8.6 vs 6.4 nmol/L/3 h (p<0.002), respectively.
Compared the results from insulin and c-peptide data, insulin
sensitivity and hepatic insulin clearance would be involved.
In response to a mixed meal challenge, GLP-1-induced
insulin secretion was found [33]. It was significantly reduced in
people with impaired glucose tolerance, compared with those
with normal glucose tolerance.
After mixed nutrient preload, glucose tolerance was relieved
in proportion to the degree of T2DM [34]. Investigating
responses to nutrient ingestion might reveal
pathophysiological mechanism of T2DM, leading to a potent
tool to improve glycemic control.
As mentioned above, researches on breakfast containing
complex nutrients are progressing. Since the content is not
single nutrient, these studies would have limits and problems
to be solved. They may include various kinds of mixture for
nutrients in the meal, different speed of digestion and
absorption for each subjects, and response ability of insulin
and C-peptide secretion. However, our current research
concerning CPI-Carbo70 might become a reference data for
future diabetic practice and research.
Conclusion
In current study, we investigated the response of blood
glucose and C-peptide for carbohydrate 70 g and proposed the
usefulness of CPI-Carb70. This index could become one of the
simple and useful tool for evaluating pancreas function and
glucose variability. This report would provide one of the basal
data in the clinical practice and research development.
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